UVRAG expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.428600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.261400E-01
Normal-vs-Stage2
3.517800E-01
Normal-vs-Stage3
2.585000E-01
Normal-vs-Stage4
3.617400E-01
Stage1-vs-Stage2
6.633200E-01
Stage1-vs-Stage3
2.405400E-01
Stage1-vs-Stage4
6.523400E-01
Stage2-vs-Stage3
1.680390E-01
Stage2-vs-Stage4
9.664200E-01
Stage3-vs-Stage4
1.731650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.428800E-01
Normal-vs-AfricanAmerican
4.263200E-01
Normal-vs-Asian
2.818800E-01
Caucasian-vs-AfricanAmerican
3.110200E-01
Caucasian-vs-Asian
1.425810E-01
AfricanAmerican-vs-Asian
7.747900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.340800E-01
Normal-vs-Female
3.538000E-01
Male-vs-Female
4.136600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.591400E-01
Normal-vs-Age(41-60Yrs)
3.931800E-01
Normal-vs-Age(61-80Yrs)
3.219800E-01
Normal-vs-Age(81-100Yrs)
3.269000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.487200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.152000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.034000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.109510E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.405380E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.842600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.255200E-01
Normal-vs-Daily Drinker
3.133200E-01
Normal-vs-Weekly Drinker
3.013800E-01
Normal-vs-Occasional Drinker
3.455400E-01
Normal-vs-Social Drinker
3.897400E-01
Non Drinker-vs-Daily Drinker
7.405600E-01
Non Drinker-vs-Weekly Drinker
5.517200E-01
Non Drinker-vs-Occasional Drinker
6.379800E-01
Non Drinker-vs-Social Drinker
2.635400E-01
Daily Drinker-vs-Weekly Drinker
7.692600E-01
Daily Drinker-vs-Occasional Drinker
4.551400E-01
Daily Drinker-vs-Social Drinker
2.023600E-01
Weekly Drinker-vs-Occasional Drinker
3.409000E-01
Weekly Drinker-vs-Social Drinker
1.864640E-01
Occasional Drinker-vs-Social Drinker
5.002600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.865170E-01
Normal-vs-Grade 2
1.452390E-02
Normal-vs-Grade 3
2.690400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.281000E-01
Grade 1-vs-Grade 3
1.967050E-01
Grade 1-vs-Grade 4
1.865170E-01
Grade 2-vs-Grade 3
8.731800E-01
Grade 2-vs-Grade 4
1.452390E-02
Grade 3-vs-Grade 4
2.690400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.342000E-01
Normal-vs-NonDiabetic
3.302000E-01
Diabetic-vs-NonDiabetic
9.086600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.043800E-01
Normal-vs-NoPancreatitis
3.257000E-01
Pancreatitis-vs-NoPancreatitis
1.189580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.419600E-01
Normal-vs-N1
3.480600E-01
N0-vs-N1
7.986600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.485800E-01
Normal-vs-TP53-NonMutant
3.296000E-01
TP53-Mutant-vs-TP53-NonMutant
5.895200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
